Miraculins Announces Completion of PREVU Skin Cholesterol Test Acquisition – MarketWatch (press release)
posted on Sep 03 by preeclampsia - Google News in the Uncategorized categoryMiraculins Announces Completion of PREVU Skin Cholesterol Test Acquisition MarketWatch (press release) The Company's lead program, a suite of biomarkers for preeclampsia, is partnered with Alere Inc. (formerly Inverness Medical Innovations) (NYSE:ALR) ... |



